Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
What symptoms are differentially present in SARS-CoV-2–infected individuals 6 months or more after infection compared with uninfected individuals? What symptom-based criteria can be used to identify postacute sequelae of SARS-CoV-2 infection cases?
Diagnosis of type 1 diabetes after SARS-CoV-2 infection: Researchers find possible correlation
Researchers at Helmholtz Munich and TU Dresden, in cooperation with the Kassenärztliche Vereinigung Bayern, have now investigated whether there is a temporal association between infection with the SARS-CoV-2 virus and the development of type 1 diabetes.
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers
Antibody levels and neutralizing activity progressively increased with each booster but subsequently waned over 3-6 months.
The impact of the SARS-CoV-2 pandemic on global influenza surveillance: Insights from 18 National Influenza Centers based on a survey conducted between November 2021 and March 2022
National Influenza Centers have played a crucial role in the surveillance of SARS-CoV-2. The FluCov project, covering 22 countries, was initiated to monitor the impact of the SARS-CoV-2 pandemic on influenza activity.
Influenza Vaccines: What Does the mRNA Platform Have to Offer?
Are you up to date about current developments in influenza vaccines with the messenger RNA (mRNA) platform?
Reaching for New Heights: Breaking Down Influenza Trends and Prevention Efforts
Did you know that in female children, influenza pneumonia is the second most common cause of death?
Prevention of long COVID: progress and challenges
Long COVID—the umbrella term that encompasses the post-acute and long-term sequelae of SARS-CoV-2 infection—can be profoundly disabling and might affect people for a lifetime.
COVID-19 evolving variants and how to stay safe
Why are we seeing a rising number of COVID-19 cases in some parts of the world? How is the SARS CoV 2 virus evolving? What do Governments and the public need to do to live with COVID-19 safely? Dr Maria Van Kerkhove explains in WHO's Science in 5.
Algorithm for Optimised mRNA Design Improves Stability and Immunogenicity
mRNA vaccines are being used to contain COVID-19, but still suffer from the critical limitation of mRNA instability and degradation, which is a major obstacle in the storage, distribution, and efficacy of the vaccine products.
Progress Report: Reducing the Burden of RSV across the Lifespan
The National Foundation for Infectious Diseases (NFID) supports RSV education by engaging key audiences, sharing firsthand experiences of RSV among all age groups, and providing resources to help raise awareness of the burden of disease.
ECDC on Air podcast: The solidarity of Vaccination
European Immunization Week is marked across Europe every year in the final week of April. It aims to raise awareness of the importance of immunisation for the general health and well-being of the European and wider population.
ReSViNET's RSV Dashboard is 𝐋𝐈𝐕𝐄!
ReSViNET Foundation is supporting healthcare decisions by providing transparency and accessibility to shared global RSV surveillance data. The dashboard will help simplify tracking changes in RSV seasonality globally.